ChLpMab-23: Cancer-Specific Human-Mouse Chimeric Anti-Podoplanin Antibody Exhibits Antitumor Activity via Antibody-Dependent Cellular Cytotoxicity.
暂无分享,去创建一个
M. Fukayama | S. Abe | Y. Nishioka | Y. Kato | M. Kaneko | S. Yamada | Takuro Nakamura | S. Ogasawara | Y. Fujii | A. Kunita | Miyuki Yanaka | Noriko Saidoh | K. Yoshida